Acadian Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-868,620
| Closed | -$754K | – | 1916 |
|
|
2023
Q2 | $754K | Sell |
868,620
-183,098
| -17% | -$131K | ﹤0.01% | 951 |
|
|
2023
Q1 | $733K | Sell |
1,051,718
-40,638
| -4% | -$32.9K | ﹤0.01% | 958 |
|
|
2022
Q4 | $894K | Buy |
1,092,356
+191,527
| +21% | +$189K | ﹤0.01% | 874 |
|
|
2022
Q3 | $936K | Buy |
900,829
+573,219
| +175% | +$916K | 0.01% | 821 |
|
|
2022
Q2 | $537K | Buy |
327,610
+107,383
| +49% | +$223K | ﹤0.01% | 953 |
|
|
2022
Q1 | $646K | Buy |
220,227
+57,013
| +35% | +$200K | ﹤0.01% | 926 |
|
|
2021
Q4 | $778K | Buy |
+163,214
| New | +$1.05M | ﹤0.01% | 892 |
|
|
2021
Q2 | – | Sell |
-579,677
| Closed | -$4.52M | – | 2272 |
|
|
2021
Q1 | $4.52M | Buy |
579,677
+163,582
| +39% | +$1.64M | 0.02% | 493 |
|
|
2020
Q4 | $3.84M | Buy |
416,095
+21,863
| +6% | +$190K | 0.01% | 578 |
|
|
2020
Q3 | $2.72M | Buy |
394,232
+147,309
| +60% | +$894K | 0.01% | 588 |
|
|
2020
Q2 | $1.62M | Buy |
246,923
+113,280
| +85% | +$409K | 0.01% | 797 |
|
|
2020
Q1 | $251K | Buy |
133,643
+26,802
| +25% | +$70.7K | ﹤0.01% | 1147 |
|
|
2019
Q4 | $201K | Hold |
106,841
| – | – | ﹤0.01% | 1292 |
|
|
2019
Q3 | $151K | Buy |
106,841
+6,721
| +7% | +$14.7K | ﹤0.01% | 1387 |
|
|
2019
Q2 | $283K | Buy |
100,120
+7,640
| +8% | +$30.4K | ﹤0.01% | 1144 |
|
|
2019
Q1 | $441K | Buy |
92,480
+79,151
| +594% | +$389K | ﹤0.01% | 1129 |
|
|
2018
Q4 | $56K | Buy |
+13,329
| New | +$103K | ﹤0.01% | 1403 |
|
Acadian Asset Management's SURF Position: Q3 2023 in Review
Acadian Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 868,620 shares — an estimated $754K sold.
Acadian Asset Management first reported a position in SURF in Q4 2018 and held it in 17 quarters. The position peaked at $4.52M in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Acadian Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Acadian Asset Management sold 868,620 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $754K.
- Acadian Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 17 quarters.
- Acadian Asset Management's Surface Oncology, Inc. Common Stock position peaked at $4.52M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.